MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced that it has been awarded a grant by the German Federal Ministry of Education and Research, BMBF. The funding of approximately EUR 1 million supports MorphoSys in accelerating the development of its HuCAL-based cancer program...